EUVIMEDEUVIMED entdecken
Crossref

The cost‐effectiveness of maternal and neonatal screening for congenital cytomegalovirus infection in Japan

Hirosato Aoki, Ari Bitnun, Taito Kitano iD

Journal of Medical Virology · 2023

DOI: 10.1002/jmv.28391 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Virology, 2023. Verfasst von Hirosato Aoki und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Nara Medical University, Kashihara, Nara, Japan. Hauptthemen laut MEDLINE: Neonatal Screening, Cytomegalovirus Infections. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 73 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Congenital cytomegalovirus infection is the most common congenital infection. Using a decision tree model, cost‐effectiveness of maternal screening with subsequent prenatal valacyclovir treatment and newborn screening with neonatal valganciclovir treatment was evaluated. The incremental cost‐effectiveness ratio (ICER) was calculated for (1) universal maternal antibody screening with prenatal valacyclovir treatment compared to targeted newborn screening, and (2) universal newborn screening with postnatal valganciclovir treatment compared to targeted newborn screening. We performed a one‐way sensitivity analysis. Compared to targeted newborn screening, the ICERs for universal newborn screening and maternal screening were 2 966 296 Japanese Yen (JPY) (21 188 USD) and 1 026 984 JPY (7336 USD), respectively. In all scenarios in the one‐way sensitivity analysis, the ICERs of the maternal screening and the universal newborn screening strategies were less than three gross domestic product per capita compared with the targeted newborn screening strategy. Both maternal and universal newborn screening strategies may be cost‐effective than a targeted newborn screening program. The potential utility of the maternal screening with valacyclovir treatment strategy, while potentially cost effective in regions with lower baseline seroprevalence rates, requires further study as the modeling was based on limited evidence.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neonatal ScreeningCytomegalovirus InfectionsInfant, NewbornPregnancyFemaleHumansCost-Benefit AnalysisValganciclovirValacyclovirJapanSeroepidemiologic Studies

Stichwörter der Autor:innen

congenitalcost-effectivenesscytomegalovirushearing lossquality-adjusted life years: screening

Substanzen

ValganciclovirValacyclovir

Autor:innen und Institutionen

  • Department of Pediatrics, Nara Medical University, Kashihara, Nara, Japan.
  • Department of Neonatology, Kanagawa Children's Medical Center, Yokohama, Kanagawa, Japan.
  • Department of Paediatrics, Division of Infectious Diseases, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.
  • Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.

ORCID-Profile: Taito Kitano

Zitieren

APA

Aoki, H., Bitnun, A., & Kitano, T. (2023). The cost‐effectiveness of maternal and neonatal screening for congenital cytomegalovirus infection in Japan. Journal of Medical Virology. https://doi.org/10.1002/jmv.28391

Vancouver

Aoki H, Bitnun A, Kitano T. The cost‐effectiveness of maternal and neonatal screening for congenital cytomegalovirus infection in Japan. Journal of Medical Virology. 2023. doi:10.1002/jmv.28391

BibTeX
@article{Aoki2023,
  author = {Aoki, Hirosato and Bitnun, Ari and Kitano, Taito},
  title = {The cost‐effectiveness of maternal and neonatal screening for congenital cytomegalovirus infection in Japan},
  journal = {Journal of Medical Virology},
  year = {2023},
  doi = {10.1002/jmv.28391}
}
Kostenlos starten →